Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
185 studies found for:    "Idiopathic thrombocytopenic purpura"
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: Immune Globulin Intravenous (Human), 10% Triple Virally Reduced Solution
2 Completed Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura
Condition: Idiopathic Thrombocytopenic Purpura
Intervention:
3 Terminated Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Biological: GMA161
4 Completed
Has Results
A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Chronic Idiopathic Thrombocytopenic Purpura
Intervention: Biological: Gammaplex, intravenous immunoglobulin
5 Unknown  Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
Condition: Acute Idiopathic Thrombocytopenic Purpura
Intervention:
6 Completed Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: Anti-D
7 Completed
Has Results
A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: rituximab [MabThera/Rituxan]
8 Completed
Has Results
A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Interventions: Drug: rituximab;   Drug: Dexamethasone
9 Active, not recruiting The Efficacy of Dexamethasone Versus Dexamethasone Combined With Rituximab in Patients With Newly Diagnosed Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Interventions: Drug: Dexamethasone;   Drug: Dexamethasone and Rituximab
10 Terminated A Phase 3, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group Trial With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Oral E5501 Versus Eltrombopag, in Adults With Chronic Immune Thrombocytopenia (Idiopathic Thrombocytopenic Purpura)
Condition: Idiopathic Thrombocytopenic Purpura
Interventions: Drug: Eltrombopag;   Drug: Avatrombopag
11 Completed Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients
Condition: Idiopathic Thrombocytopenic Purpura (ITP)
Intervention: Drug: PG2
12 Recruiting Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
Condition: Chronic Idiopathic Thrombocytopenic Purpura
Intervention: Drug: Hetrombopag Olamine
13 Completed Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients
Condition: Idiopathic Thrombocytopenic Purpura (ITP)
Intervention: Drug: IgNextGen 10%
14 Completed Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag
Condition: Idiopathic Thrombocytopenic Purpura
Interventions: Drug: eltrombopag;   Drug: corticosteroids (Aprednislon)
15 Completed Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura
Conditions: Idiopathic Thrombocytopenic Purpura;   Immune Thrombocytopenic Purpura
Intervention: Biological: Inactivated Trivalent Influenza vaccine
16 Completed Evaluating the Safety and Efficacy of AMG531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura(ITP)
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: AMG 531
17 Completed Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Chronic Idiopathic Thrombocytopenic Purpura;   Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Placebo;   Drug: AKR-501 Tablets
18 Unknown  Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura
Condition: Autoimmune Thrombocytopenic Purpura
Intervention: Drug: Doxil
19 Completed Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura
Conditions: Chronic Idiopathic Thrombocytopenic Purpura;   Helicobacter Pylori Infection
Intervention: Drug: lansoprazole, clarithromycin, amoxycillin
20 Completed Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Idiopathic Thrombocytopenic Purpura (ITP);   Immune Thrombocytopenic Purpura (ITP)
Intervention: Drug: rituximab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.